M1 Kliniken AG (STU:M12) EPS (Basic): €1.19 (TTM As of Dec. 2025)

What is M1 Kliniken AG EPS (Basic)?

M1 Kliniken AG STU:M12 -0.77% 92 EPS (Basic) is €1.19 as of Dec. 2025. GuruFocus rates STU:M12 with a GF Score™ of 92/100 and a GF Value™ of €15.98 (Modestly Overvalued). The stock has 3 warning signs investors should review.

M1 Kliniken AG's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was €0.56. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.19.

M1 Kliniken AG's EPS (Diluted) for the six months ended in Dec. 2025 was €0.56. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.19.

M1 Kliniken AG's EPS without NRI for the six months ended in Dec. 2025 was €0.59. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 1.25.

During the past 12 months, M1 Kliniken AG's average EPS without NRIGrowth Rate was 52.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 79.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 33.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, M1 Kliniken AG's highest 3-Year average EPS without NRI Growth Rate was 79.30% per year. The lowest was -19.40% per year. And the median was 7.80% per year.

M1 Kliniken AG (STU:M12) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

M1 Kliniken AG EPS (Basic) Related Terms

M1 Kliniken AG EPS (Basic) Historical Data

* Premium members only.

The historical data trend for M1 Kliniken AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M1 Kliniken AG EPS (Basic) Chart

M1 Kliniken AG Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

0.45

0.24

0.54

0.85

1.19

M1 Kliniken AG Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
EPS (Basic)	Get a 7-Day Free Trial															0.37	0.53	0.32	0.63	0.56

92GF Score

M1 Kliniken AG STU:M12

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

M1 Kliniken AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

M1 Kliniken AG's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(22.132	-	0)	/	19.643
	=	1.13

M1 Kliniken AG's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(10.511	-	0)	/	20.840
	=	0.50

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.19

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of €1.19 mean?

M1 Kliniken AG (STU:M12) has a EPS (Basic) of €1.19 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on M1 Kliniken AG and its competitors.

Is M1 Kliniken AG's EPS (Basic) too high?

M1 Kliniken AG's current EPS (Basic) is €1.19. Overall, M1 Kliniken AG has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does M1 Kliniken AG's EPS (Basic) compare to MCK and COR?

M1 Kliniken AG's EPS (Basic) of €1.19 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Distribution company?

A good EPS (Basic) depends on the Medical Distribution industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on M1 Kliniken AG and its competitors. M1 Kliniken AG's current EPS (Basic) is €1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is M1 Kliniken AG stock overvalued right now?

Based on GuruFocus' analysis, M1 Kliniken AG (STU:M12) is currently considered Modestly Overvalued. The stock's GF Value™ is €15.98, compared to a current price of €18.02 — trading 12.8% above its estimated fair value. The current EPS (Basic) is €1.19. M1 Kliniken AG's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For M1 Kliniken AG (STU:M12), the current EPS (Basic) is €1.19 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M1 Kliniken AG (STU:M12) Overvalued in 2026?

Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued. The current stock price of €18.02 is trading 12.8% above its estimated GF Value™ of €15.98. GuruFocus considers M1 Kliniken AG to be Modestly Overvalued.

Key valuation signals for STU:M12:

EPS (Basic): €1.19
GF Value™: €15.98 vs. price of €18.02 (12.8% above fair value)
GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the STU:M12 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M1 Kliniken AG Business Description

Industry Healthcare Medical Distribution

Comparable Companies FRA:ILM1 STU:BMP FRA:TLIK MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 TSE:2784 SHSE:600739 NZSE:EBO

Other Exchanges M12:Germany

Address Grunauer strasse 5, Berlin, BB, DEU, 12557

Website https://www.m1-kliniken.de

M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.

92GF Score

Get the complete analysis for STU:M12

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.02

Price

€15.98

GF Value

View STU:M12 Analysis

See EPS (Basic) data for all stocks →